Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (161-170 of 429) with videos related to

Pageof 43
Sort By:
Human Genetics|April 30, 2018
High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputationTodd Lencz, Jin Yu, Cameron Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Cancer|October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinomaA Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.
Nature Medicine|July 26, 2011
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaTimothy Best, Dalin Li, Andrew D Skol, et al.
Cancer Research|April 1, 2008
The signatures of autozygosity among patients with colorectal cancerManny D Bacolod, Gunter S Schemmann, Shuang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.
JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Pageof 43

Showing results (161-170 of 429) with videos related to

Sort By:
Pageof 43
Human Genetics|April 30, 2018
High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputationTodd Lencz, Jin Yu, Cameron Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Cancer|October 28, 2015
Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinomaA Ari Hakimi, Irina Ostrovnaya, Anders Jacobsen, et al.
NPJ Precision Oncology|January 2, 2023
Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterationsDiana Mandelker, Antonio Marra, Nikita Mehta, et al.
NPJ Breast Cancer|October 12, 2021
Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombinationJeremy Setton, Pier Selenica, Semanti Mukherjee, et al.
Nature Medicine|July 26, 2011
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphomaTimothy Best, Dalin Li, Andrew D Skol, et al.
Cancer Research|April 1, 2008
The signatures of autozygosity among patients with colorectal cancerManny D Bacolod, Gunter S Schemmann, Shuang Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate CancerKonrad H Stopsack, Joseph Vijai, Michael Conry, et al.
JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
Scientific Reports|November 23, 2023
Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinomaAurel Prosz, Haohui Duan, Viktoria Tisza, et al.
Pageof 43